Michelle M. Vu

548 total citations
3 papers, 63 citations indexed

About

Michelle M. Vu is a scholar working on Cardiology and Cardiovascular Medicine, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Michelle M. Vu has authored 3 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cardiology and Cardiovascular Medicine, 1 paper in Organic Chemistry and 1 paper in Molecular Biology. Recurrent topics in Michelle M. Vu's work include Cardiac electrophysiology and arrhythmias (2 papers), HER2/EGFR in Cancer Research (1 paper) and Cardiac pacing and defibrillation studies (1 paper). Michelle M. Vu is often cited by papers focused on Cardiac electrophysiology and arrhythmias (2 papers), HER2/EGFR in Cancer Research (1 paper) and Cardiac pacing and defibrillation studies (1 paper). Michelle M. Vu collaborates with scholars based in United States and India. Michelle M. Vu's co-authors include Dries Feyen, Ricardo Serrano, Arne A.N. Bruyneel, Mark Mercola, Robert S. Kass, A. K. Savchenko, Kevin J. Sampson, Prashila Amatya, F Potet and John R. Cashman and has published in prestigious journals such as Cancer Research and Cell stem cell.

In The Last Decade

Michelle M. Vu

3 papers receiving 61 citations

Peers

Countries citing papers authored by Michelle M. Vu

Since Specialization

Citations

This map shows the geographic impact of Michelle M. Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle M. Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle M. Vu more than expected).

Fields of papers citing papers by Michelle M. Vu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle M. Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle M. Vu. The network helps show where Michelle M. Vu may publish in the future.

Co-authorship network of co-authors of Michelle M. Vu

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle M. Vu. A scholar is included among the top collaborators of Michelle M. Vu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle M. Vu. Michelle M. Vu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

#	Work	Indexed citations
1	Reengineering Ponatinib to Minimize Cardiovascular Toxicity 2022 ·Cancer Research ·(unknown), Arne A.N. Bruyneel, Dhanir Tailor, Mallesh Pandrala, (unknown), Wenqi Li, Ricardo Serrano, Dries Feyen, Michelle M. Vu, Prashila Amatya, (unknown), Yusuke Nakauchi, Isabel Morgado, Volker Wiebking, Ronglih Liao, Matthew H. Porteus, Ravindra Majeti, Sanjay V. Malhotra, Mark Mercola	14
2	A deep learning platform to assess drug proarrhythmia risk 2022 ·Cell stem cell ·Ricardo Serrano, Dries Feyen, Arne A.N. Bruyneel, (unknown), Michelle M. Vu, Prashila Amatya, Isaac Perea‐Gil, (unknown), Timon Seeger, Joseph C. Wu, Ioannis Karakikes, Mark Mercola	14
3	Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity 2020 ·Cell stem cell ·Wesley L. McKeithan, Dries Feyen, Arne A.N. Bruyneel, Karl J. Okolotowicz, Daniel A. J. Ryan, Kevin J. Sampson, F Potet, A. K. Savchenko, Jorge Gomez‐Galeno, Michelle M. Vu, Ricardo Serrano, Alfred L. George, Robert S. Kass, John R. Cashman, Mark Mercola	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact